Takeaways from this week in optometry: June 9

Published on June 14, 2025
Catch up on the top stories in optometry during the week of June 9-June 13.
Continue reading on website
Other news

Qlaris Bio announces development of QLS-111-FDC

June 13, 2025
This new QLS-111 and latanoprost fixed-dose combination (QLS-111-FDC; Qlaris) is in development for the treatment of primary open angle glaucoma, ocular hypertension, and normal tension glaucoma for patients whom optimal intraocular pressure control may remain “unachievable” due to needing to lower episcleral venous pressure.

Endophthalmitis Rate Post-PPV Found to Be Low

June 16, 2025
Patients aged 85 years or older were more likely to develop postoperative endophthalmitis following pars plana vitrectomy in this study compared to those aged 65 to 74 years. Photo: Wikimedia Commons/Journal of Ophthalmology, Liu X et al. Click image to enlarge. Pars plana vitrectomy (PPV) is currently the most common surgical approach to retinal diseases such as retin